Jessica Boklan

Constitutional <i>SAMD9L</i> mutations cause familial myelodysplastic syndrome and transient monosomy 7

Victor B. Pastor, Sushree Sangita Sahoo, Jessica Boklan et al. · Haematologica · 2017 · 103 citations · Full text

Life Sciences, Genetics, Hematology +17

Phase I Pharmacokinetic and Pharmacodynamic Study of 17-<i>N</i>-Allylamino-17-Demethoxygeldanamycin in Pediatric Patients with Recurrent or Refractory Solid Tumors: A Pediatric Oncology Experimental Therapeutics Investigators Consortium Study

Rochelle Bagatell, Lia Gore, Merrill J. Egorin et al. · Clinical Cancer Research · 2007 · 92 citations · Full text

Medicine, Oncology, Pharmacology +17

A phase 1 study of the CXCR4 antagonist plerixafor in combination with high‐dose cytarabine and etoposide in children with relapsed or refractory acute leukemias or myelodysplastic syndrome: A Pediatric Oncology Experimental Therapeutics Investigators’ Consortium study (POE 10‐03)

Todd M. Cooper, Edward Allan R. Sison, Sharyn D. Baker et al. · Pediatric Blood & Cancer · 2017 · 73 citations · Full text

Medicine, Oncology, Pharmacology +17

Immunosuppressive therapy for pediatric aplastic anemia: a North American Pediatric Aplastic Anemia Consortium study

Zora R. Rogers, Taizo A. Nakano, Timothy S. Olson et al. · Haematologica · 2019 · 67 citations · Full text

Medicine, Hematology, Pediatrics +17

Potentiation of reactive oxygen species is a marker for synergistic cytotoxicity of MS-275 and 5-azacytidine in leukemic cells

Shan Gao, Aaron Mobley, Claudia P. Miller et al. · Leukemia Research · 2007 · 55 citations · Full text

Medicine, Oncology, Pharmacology +14